147 related articles for article (PubMed ID: 9857058)
1. Degradation of proto-oncoprotein c-Rel by the ubiquitin-proteasome pathway.
Chen E; Hrdlickova R; Nehyba J; Longo DL; Bose HR; Li CC
J Biol Chem; 1998 Dec; 273(52):35201-7. PubMed ID: 9857058
[TBL] [Abstract][Full Text] [Related]
2. A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells.
Shumway SD; Miyamoto S
Biochem J; 2004 May; 380(Pt 1):173-80. PubMed ID: 14763901
[TBL] [Abstract][Full Text] [Related]
3. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
Palombella VJ; Rando OJ; Goldberg AL; Maniatis T
Cell; 1994 Sep; 78(5):773-85. PubMed ID: 8087845
[TBL] [Abstract][Full Text] [Related]
4. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
[TBL] [Abstract][Full Text] [Related]
5. Activation of NF-kappa B/Rel by Tax involves degradation of I kappa B alpha and is blocked by a proteasome inhibitor.
Maggirwar SB; Harhaj E; Sun SC
Oncogene; 1995 Sep; 11(5):993-8. PubMed ID: 7675460
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132.
Fiedler MA; Wernke-Dollries K; Stark JM
Am J Respir Cell Mol Biol; 1998 Aug; 19(2):259-68. PubMed ID: 9698598
[TBL] [Abstract][Full Text] [Related]
7. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells.
Gregory MA; Hann SR
Mol Cell Biol; 2000 Apr; 20(7):2423-35. PubMed ID: 10713166
[TBL] [Abstract][Full Text] [Related]
8. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.
Scherer DC; Brockman JA; Chen Z; Maniatis T; Ballard DW
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11259-63. PubMed ID: 7479976
[TBL] [Abstract][Full Text] [Related]
9. Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression.
Li B; Dou QP
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):3850-5. PubMed ID: 10725400
[TBL] [Abstract][Full Text] [Related]
10. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo.
Krappmann D; Wulczyn FG; Scheidereit C
EMBO J; 1996 Dec; 15(23):6716-26. PubMed ID: 8978697
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells.
Marienfeld R; Neumann M; Chuvpilo S; Escher C; Kneitz B; Avots A; Schimpl A; Serfling E
Eur J Immunol; 1997 Jul; 27(7):1601-9. PubMed ID: 9247567
[TBL] [Abstract][Full Text] [Related]
12. Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells.
O'Connor S; Shumway SD; Amanna IJ; Hayes CE; Miyamoto S
Mol Cell Biol; 2004 Jun; 24(11):4895-908. PubMed ID: 15143182
[TBL] [Abstract][Full Text] [Related]
13. Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis.
Palombella VJ; Conner EM; Fuseler JW; Destree A; Davis JM; Laroux FS; Wolf RE; Huang J; Brand S; Elliott PJ; Lazarus D; McCormack T; Parent L; Stein R; Adams J; Grisham MB
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15671-6. PubMed ID: 9861028
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of IkappaB-alpha and IkappaB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis.
Milligan SA; Owens MW; Grisham MB
Arch Biochem Biophys; 1996 Nov; 335(2):388-95. PubMed ID: 8914937
[TBL] [Abstract][Full Text] [Related]
15. Persistent activation of NF-kappa B/Rel by human T-cell leukemia virus type 1 tax involves degradation of I kappa B beta.
Good L; Sun SC
J Virol; 1996 May; 70(5):2730-5. PubMed ID: 8627746
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase.
Yaron A; Gonen H; Alkalay I; Hatzubai A; Jung S; Beyth S; Mercurio F; Manning AM; Ciechanover A; Ben-Neriah Y
EMBO J; 1997 Nov; 16(21):6486-94. PubMed ID: 9351830
[TBL] [Abstract][Full Text] [Related]
17. Basal phosphorylation of the PEST domain in the I(kappa)B(beta) regulates its functional interaction with the c-rel proto-oncogene product.
Chu ZL; McKinsey TA; Liu L; Qi X; Ballard DW
Mol Cell Biol; 1996 Nov; 16(11):5974-84. PubMed ID: 8887627
[TBL] [Abstract][Full Text] [Related]
18. Degradation of transcription factor IRF-1 by the ubiquitin-proteasome pathway. The C-terminal region governs the protein stability.
Nakagawa K; Yokosawa H
Eur J Biochem; 2000 Mar; 267(6):1680-6. PubMed ID: 10712599
[TBL] [Abstract][Full Text] [Related]
19. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.
Rodriguez MS; Desterro JM; Lain S; Lane DP; Hay RT
Mol Cell Biol; 2000 Nov; 20(22):8458-67. PubMed ID: 11046142
[TBL] [Abstract][Full Text] [Related]
20. A caspase-3-like protease is involved in NF-kappaB activation induced by stimulation of N-methyl-D-aspartate receptors in rat striatum.
Qin Z; Wang Y; Chasea TN
Brain Res Mol Brain Res; 2000 Sep; 80(2):111-22. PubMed ID: 11038244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
